 Clarivate Plc NYSE:CCC, a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of Cortellis Generics IntelligenceTM to enable generics companies and Active Pharmaceutical Ingredient API manufacturers to make timely and more informed data-driven decisions as they seek to drive business growth, identify new markets, products and partners, defend market share and more. The modern, intuitive platform enables sourcing, business development, portfolio and intellectual property teams within an organization to make data-driven decisions all from a single application. 